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Background
Immunological characterization of acute/early HIV-1
infection is important for the design of effective vaccine
capable of neutralizing early transmitted virus. However,
while recently there is significant progress in our under-
standing of the nature of such virus, our knowledge of the
antibodies elicited during this period and their dynamics
is scarce. In particular, there are no such well characterized
human monoclonal antibodies (mAbs).
Methods
We constructed phage-displayed antibody libraries from
the bone marrow and peripheral blood obtained from an
acutely infected patient 40 days and 8 months post infec-
tion. Several high-affinity mAbs were selected from these
libraries by using recombinant soluble gp120-gp41s
(gp140s, Envs) as antigens for panning and screening.
Results
Two of these antibodies were more extensively character-
ized. They bound to the selecting antigen but not to heter-
ologous Envs and had limited neutralizing activity.
Compared to the closest germline antibodies they had
only several clonally related mutations – much less than
known broadly neutralizing antibodies. More extensive
characterization of these and newly identified mAbs as
well as identification of new mAbs is in progress.
Conclusion
Previous studies have shown that selection of high-affinity
antibodies from such libraries result in antibodies which
are identical or very similar to those occurring in the host
from which the libraries are made. These results indicate
that during an acute infection the Env could elicit anti-
bodies that are not significantly divergent from the corre-
sponding germline antibodies but of significantly high
neutralizing activity to possibly affect the virus dynamics.
Further characterization of these antibodies, their dynam-
ics and epitopes could provide knowledge that in addition
to its usefulness for basic understanding of immune
responses to HIV-1 could also help in the design of candi-
date vaccine immunogens that elicit potent neutralizers of
early transmitted virus.
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